Literature DB >> 8536382

Recombinant soluble Fc gamma RII inhibits immune complex precipitation.

A L Gavin1, B D Wines, M S Powell, P M Hogarth.   

Abstract

Control of IgG immune complex formation and deposition is important in determining the nature and extent of subsequent immune effector responses, and appears to be aberrant in some autoimmune diseases. In this study we demonstrate that recombinant soluble Fc gamma RII (rsFc gamma RII) is an effective modulator of immune complex formation, delaying immune precipitation in a manner which is dose-dependent, and can be specifically inhibited by anti-Fc gamma RII MoAb Fab' fragments. This inhibitory role in immune precipitation also provides a possible mechanistic explanation for our previous demonstration of the efficacy of rsFc gamma RII as an inhibitor of immune complex-induced inflammation in the Arthus reaction in vivo. RsFc gamma RII inhibited immune complex precipitation in two different experimental systems. First, rsFc gamma RII inhibited the precipitation of 125I-bovine serum albumin (BSA)-anti-BSA complexes in a dose-dependent manner, while an irrelevant protein (soybean trypsin inhibitor) had no effect on the precipitation of the immune complexes. Moreover, rsFc gamma RII inhibited the precipitation of ovalbumin (OVA)-anti-OVA complexes as determined by turbidimetric analysis, where the inhibition of immune complex precipitation by rsFc gamma RII was dose-dependent and was specifically blocked by prior incubation with Fab' fragments of a blocking MoAb to Fc gamma RII. RsFc gamma RII could inhibit the precipitation of BSA-anti-BSA complexes in the presence of excess bystander IgG and did not inhibit complement-mediated prevention of immune precipitation, demonstrating that rsFc gamma RII did not block C1 binding to the BSA-anti-BSA complex. Unlike complement, rsFc gamma RII could not cause re-solubilization of pre-formed precipitated BSA-anti-BSA complexes. Soluble Fc gamma Rs have been detected in biological fluids of normal and inflammatory disease patients, yet the role of sFc gamma R is still unclear. However, they now play a potential role in the modulation of immune complex solubility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536382      PMCID: PMC1553390          DOI: 10.1111/j.1365-2249.1995.tb03862.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Prevention of immune precipitation by purified components of the alternative pathway.

Authors:  J K Naama; E Holme; E Hamilton; K Whaley
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 2.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

3.  Mechanism of human monocyte activation via the 40-kDa Fc receptor for IgG.

Authors:  E A MacIntyre; P J Roberts; R Abdul-Gaffar; K O'Flynn; G R Pilkington; F Farace; J Morgan; D C Linch
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

4.  Recombinant human IgG1-murine IgE chimeric Ig. Construction, expression, and binding to human Fc gamma receptors.

Authors:  B Shopes; M Weetall; D Holowka; B Baird
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

5.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

6.  Detection and quantification of secreted soluble Fc gamma RIIA in human sera by an enzyme-linked immunosorbent assay.

Authors:  A Astier; H de la Salle; J Moncuit; M Freund; J P Cazenave; W H Fridman; D Hanau; J L Teillaud
Journal:  J Immunol Methods       Date:  1993-11-05       Impact factor: 2.303

7.  IgM-RF prevents complement-mediated inhibition of immune precipitation.

Authors:  W S Mitchell; J K Naama; J Veitch; K Whaley
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

8.  The oligosaccharide units of rabbit immunoglobulin G. Asymmetric attachment of C2-oligosaccharide.

Authors:  M W Fanger; D G Smyth
Journal:  Biochem J       Date:  1972-05       Impact factor: 3.857

9.  Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.

Authors:  F L Ierino; M D Hulett; I F McKenzie; P M Hogarth
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

10.  The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon.

Authors:  C G COCHRANE; W O WEIGLE
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptide.

Authors:  Jun Xi; Gai P Zhang; Song L Qiao; Jun Q Guo; Xuan N Wang; Yan Y Yang; Li N Zhang; Xian W Miao; Dong Zhao; Yu B Zhi; Shu J Cai; Jun Luo; Rui G Deng
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.

Authors:  Bruce D Wines; Amanda Gavin; Maree S Powell; Michael Steinitz; Russell R C Buchanan; P Mark Hogarth
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

4.  A soluble FcγR homolog inhibits IgM antibody production in ayu spleen cells.

Authors:  Kai Chen; Yu-Hong Shi; Jiong Chen; Ming-Yun Li
Journal:  Zool Res       Date:  2019-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.